Narodowy Program Wyrównywania Dostępności Do Profilaktyki I Leczenia Chorób Układu Sercowo-Naczyniowego

Objectives

POLKARD for 2013–2016 is a national cardiovascular prevention and treatment programme intended to reduce equipment-related disparities in access to highly specialised services and, in the longer term, reduce cardiovascular morbidity, mortality, disability and premature death.[1]It continues earlier Polish cardiovascular programmes and responds to cardiovascular disease as the leading cause of death in Poland, alongside substantial demand for hospital care and persistent risk-factor exposure.[2][3]

• Improve access to cardiology, cardiac surgery, paediatric cardiology, neurology, neurological rehabilitation and vascular-surgery services by supplying or replacing obsolete medical equipment.[1][4]
• Strengthen capacity for complex cardiovascular care, including hybrid operating rooms, electrophysiology, paediatric haemodynamics, vascular surgery, acute stroke treatment, post-stroke rehabilitation and cardiac monitoring in internal-medicine wards.[5][6][7][8]
• Reduce preventable cardiovascular risk through public education, healthier lifestyles, physical activity, secondary prevention and early mobilisation after myocardial infarction.[9][10][11]
• Expand early detection of vascular conditions through abdominal aortic aneurysm screening, assessment of lower-limb peripheral arterial disease and surveillance of venous leg ulceration.[12][13][14]
• Generate evidence on cardiovascular epidemiology, risk factors, mortality, hospitalisation and treatment through WOBASZ II, mortality and hospitalisation analyses, and national clinical registries.[15][16][17]

The programme frames prevention as a major priority because key modifiable risks include smoking, unhealthy diet, excess alcohol consumption, obesity and insufficient physical activity.[18][19]It also seeks to reduce regional and institutional inequalities in diagnosis and treatment, including barriers linked to patients’ place of residence and uneven specialist capacity.[20][21]

Its specialised clinical priorities include treatment of acute coronary syndromes, heart failure, stroke, peripheral vascular disease and complex cardiac and aortic conditions.[22][23]A further priority was non-surgical mitral-valve repair using MitraClip for high-risk patients ineligible for cardiac surgery, although this activity was no longer planned for ministerial funding in 2016 after becoming a guaranteed highly specialised health benefit.[24]

Implementation

POLKARD is delivered principally through competitively selected implementers, targeted equipment purchases, prevention and education activities, screening projects, epidemiological studies and designated national registries.[24][17]Financing is primarily provided through the Minister of Health’s budget, while National Health Fund financing generally covers health-service tasks; the programme finances organisational activities, new care solutions, education and essential equipment where these cannot be met from implementers’ own resources.[25][9]

• Procure equipment for hybrid rooms, including digital angiography and systems for anaesthesia, ventilation, cardiopulmonary support, haemofiltration, infusion, defibrillation and patient transfer.[22]
• Locate at least one suitable hybrid-treatment centre in each voivodeship within a multispecialty hospital with the necessary specialist departments, prioritising experienced cardiac-surgery and interventional-cardiology centres.[22][23]
• Provide C-arm X-ray systems for vascular surgery, equipment for stroke and interventional-stroke centres, and virtual-reality, movement-assistance and exercise equipment for post-stroke rehabilitation.[7][26][27]
• Equip electrophysiology laboratories with stationary X-ray systems and lead-removal technology, and provide paediatric cardiology departments with echocardiography, exercise-testing, angiography and Holter electrocardiography equipment.[6][21]
• Purchase haemodynamic monitors, central-monitoring computer stations, ambulatory blood-pressure monitors, pulse oximeters and electrocardiographs for internal-medicine wards lacking specialist cardiac-monitoring capacity.[8][28]

Population-level prevention is to use modern social-marketing and communication methods, including education for secondary-school pupils through the SYNDROM programme and a comprehensive primary-prevention model for medium-sized non-metropolitan municipalities.[10][16][29]The municipal model combines population-wide lifestyle measures with targeted support, preventive examinations and care for people at high cardiovascular risk, with intended financial participation by local-government units.[29]

Screening and specialist-referral pathways form another delivery mechanism. The abdominal aortic aneurysm programme planned ultrasonography for men over 65 with at least three cardiovascular risk factors, followed by advice, surveillance, vascular-surgery referral or operative assessment when the aortic diameter exceeded 3 centimetres.[30]Lower-limb arterial-disease and venous-ulcer activities combine primary-care assessment, specialist referral, arranged appointments for eligible patients and avoidance of duplicate payment for services covered by National Health Fund contracts.[13][14]

Monitoring draws on the Central Statistical Office, the Social Insurance Institution, hospitalisation and mortality analyses, WOBASZ II and clinical registries.[20][15]The National Register of Cardiac Surgery Operations is assigned to the Institute Children’s Memorial Health Centre, while the National Register of Acute Coronary Syndromes is assigned to the Silesian Centre for Heart Diseases in Zabrze.[31]These registries support analysis of health status, healthcare demand, treatment patterns, clinical epidemiology and prognosis.[29][31]

Equipment purchasers were expected to provide at least 15% co-financing for equipment and apparatus purchases, with specialised equipment defined as having a unit price above 10,000 Polish zloty.[25]The programme budget for 2013–2016 was planned at 59,360,041.10 Polish zloty, although annual allocations, particularly for 2016, were subject to ministerial budget decisions.[32][33]The supplied material does not specify a complete programme-wide accountability structure, reporting timetable or unified performance-indicator framework.[11][17]

Monitoring & Evaluation

Monitoring combines administrative, clinical-registry, epidemiological, screening and hospital-activity information, but the material does not set out a single programme-wide performance framework, reporting timetable, evaluation design or formal accountability structure.[32][9][17]

• Operate medical registers covering disease occurrence, health status, diagnostic and treatment methods, treatment progress and disease-related risks through healthcare entities designated under relevant regulations.[32]
• Maintain the National Registry of Cardiac Surgery Operations through the Institute Children’s Memorial Health Centre and the National Registry of Acute Coronary Syndromes through the Silesian Centre for Heart Diseases in Zabrze. The registries support monitoring of healthcare demand, cardiac-surgery activity, acute-coronary-syndrome epidemiology, treatment changes and prognostic factors.[29][31]
• Conduct the WOBASZ II nationwide multi-centre study to assess cardiovascular risk factors, health status, prevention knowledge and changes in the prevalence, control and treatment of risk factors over eight years.[15]
• Monitor premature and overall cardiovascular mortality and hospitalisation by age, sex and individual condition, using information including Central Statistical Office and Social Insurance Institution data.[20][15][17]
• Track hospitalised morbidity, hospital mortality, hospitalisation counts and rates, and average length of stay. Reported measures include a 5.7% overall in-hospital mortality rate for cardiovascular disease in 2011 and diagnosis-specific mortality measures for myocardial infarction, heart failure, pulmonary embolism, cerebrovascular disease and cardiac arrest.[34][35]
• Monitor screening coverage, follow-up and referrals in abdominal aortic aneurysm screening, which planned examinations for 20,000 men and annual follow-up for 800 men.[30]
• Collect primary-care questionnaires and specialist-clinic information on venous leg ulceration, with implementation reports and prevalence data transmitted to a coordinating centre for analysis.[14]
• Use service-capacity and access data, including equipment provision, procedure volumes, waiting times, specialist availability and stroke-service capacity, as contextual evidence for programme planning.[36][26]

Available evidence identifies important constraints: much cardiovascular statistical information is released only after delays of several years, and the Central Statistical Office does not produce dedicated cardiovascular-statistics publications.[37]Although the programme justification calls for appropriate indicators to demonstrate links with other health-policy programmes, detailed targets, indicator definitions, reporting responsibilities and performance thresholds are not specified in the supplied material.[9]

Costing & Financing

POLKARD is principally financed from the Minister of Health’s budget, while healthcare-service tasks are generally financed by the National Health Fund. Ministerial funding covers organisational activities, new care solutions, health education and essential medical equipment; territorial self-government bodies and implementers may also contribute to infrastructure and equipment purchases.[25]

• Allocate planned programme funding of 10,516,909.10 Polish zloty in 2013, 13,344,129 Polish zloty in 2014, 15,929,000 Polish zloty in 2015 and 19,570,003 Polish zloty in 2016, totalling 59,360,041.10 Polish zloty.[32]
• Recognise that the 2016 allocation may change because funding under budget chapter 85149, Health Policy Programmes, is decided annually by Ministry leadership.[33]
• Require implementers to provide at least 15% co-financing for equipment and apparatus purchases; specialised equipment is defined as having a unit price above 10,000 Polish zloty.[25]
• Prioritise capital expenditure because implementing institutions reported equipment needs. Capital-task shares were 70% in 2003-2005, 75% in 2006-2008 and 77% in 2009, while current-task shares were 30%, 25% and 23% respectively.[11]
• Record use of 94% of allocated funds in 2009-2010 and 87% in 2012.[11]
• Fund specialised activities including cardiology, paediatric cardiology and cardiac surgery, vascular surgery, stroke care, neurological rehabilitation, internal-medicine monitoring, screening, epidemiology, prevention and national registries.[6][7][8][16]
• Identify an equipment-financing gap because many planned tasks cannot be met from implementers’ own resources; continued central co-financing is presented as necessary to sustain earlier gains in access to specialised care.[36][9][2]
• Avoid duplicate financing where services are already reimbursed through National Health Fund contracts, including specialist consultations and diagnostic investigations.[13][14]

Prevention expenditure was planned at 2,935,000 Polish zloty in 2010, no funds in 2011, 2,852,000 Polish zloty in 2012, 3,778,000 Polish zloty in 2013, 4,858,822 Polish zloty in 2014 and 3,179,572 Polish zloty in 2015.[3]Prevention is presented as economically justified, while cited Organisation for Economic Co-operation and Development evidence indicates that prevention and health promotion represented 3% of health expenditure.[3]

The supplied material does not provide unit costs for most equipment, a full consolidated budget across every task, a quantified overall funding gap, or broader economic assumptions.[9][7][15]